MAAT.PA Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 10:59):

MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors...

Stats
Today's Volume	218.00
Average Volume	1 588.00
Market Cap	102.22M
EPS	€0 ( 2023-11-09 )
Last Dividend	€0 ( N/A )
Next Dividend	€0 ( N/A )
P/E	-5.18
ATR14	€0 (0.00%)

MaaT Pharma SA Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MaaT Pharma SA Financials

Annual	2023
Revenue:	€2.23M
Gross Profit:	€784 000 (35.19 %)
EPS:	€-1.730

Q4	2023
Revenue:	€850 000
Gross Profit:	€-110 000 (-12.94 %)
EPS:	€-0.970

Q2	2023
Revenue:	€1.38M
Gross Profit:	€894 000 (64.88 %)
EPS:	€-0.760

Q1	2023
Revenue:	€689 000
Gross Profit:	€547 000 (79.39 %)
EPS:	€-0.380

Financial Reports:

No articles found.

MaaT Pharma SA